Erika Suzuki

Institute Sr Rsch Scientist

    Calculated based on number of publications stored in Pure and citations from Scopus
    20092022

    Research activity per year

    Network

    Iannis E. Adamopoulos

    • University of California at Davis
    • Shriners Hospitals for Children
    • Merck

    External person

    Jeffrey J. Kovacs

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Timothy P. Heffernan

    • University of Texas MD Anderson Cancer Center
    • Harvard University
    • Dana-Farber Cancer Institute
    • University of Texas MD Anderson Cancer Center
    • C4 Therapeutics
    • Institute for Applied Cancer Science
    • Center for Co-Clinical Trials
    • Belfer Institute for Applied Cancer Science
    • Department of Medical Oncology
    • Belfer Institute for Applied Cancer Science
    • Department of Medical Oncology
    • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
    • Cornell University
    • Department of Medicine
    • University of Texas at Austin
    • Institute for Applied Cancer Science
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston
    • C4 Therapeutics, Inc.

    External person

    Mark K. Bennett

    • Proteolix, Inc.
    • Calithera Biosciences
    • Calithera Biosciences
    • Onyx Pharmaceuticals
    • Inc.

    External person

    Francesco Parlati

    • Calithera Biosciences
    • Calithera Biosciences
    • Onyx Pharmaceuticals
    • Proteolix, Inc.
    • Inc.

    External person

    Emanual Maverakis

    • VA Medical Center
    • University of California at Davis
    • Department of Dermatology
    • Department of Dermatology
    • Department of Dermatology
    • Immune Monitoring Core
    • Department of Veterans Affairs

    External person

    Monette Aujay

    • LLC
    • Stem CentRx
    • Department of Cancer Biology
    • Onyx Pharmaceuticals
    • Proteolix, Inc.

    External person

    P. H. Jones

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Institute for Applied Cancer Science
    • Institute for Applied Cancer Science
    • University of Texas at Austin
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Susan D. Demo

    • Proteolix, Inc.
    • Calithera Biosciences
    • Onyx Pharmaceuticals

    External person

    C. J. Kirk

    • Onyx Pharmaceuticals
    • Kezar Life Sciences, Inc. South San Francisco
    • Proteolix, Inc.

    External person

    Catherine Sylvain

    • Proteolix, Inc.

    External person

    Joseph R. Marszalek

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
    • Center for Co-Clinical Trials
    • Center for Co-Clinical Trials and Institute for Applied Cancer Science
    • University of Texas at Austin
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston
    • Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION)
    • Center for Co-Clinical Trials and Institute for Applied Cancer Science

    External person

    Eileen R. Ring

    • Proteolix, Inc.

    External person

    Guang Gao

    • University of Texas MD Anderson Cancer Center

    External person

    Jason B. Cross

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Jamie Shields

    • Proteolix, Inc.

    External person

    Angela L. Harris

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston
    • Lexicon Genetics Incorporated
    • Department of Metabolism Research

    External person

    Chiu Yi Liu

    • University of Texas MD Anderson Cancer Center

    External person

    Robert A. Mullinax

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Center for Co-Clinical Trials
    • Lexicon Genetics Incorporated

    External person

    Marcus Groettrup

    • Humboldt University
    • Humboldt University Berlin
    • Humboldt University of Berlin
    • Institute for Biochemistry
    • University of Konstanz

    External person

    Mike Peoples

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Center for Co-Clinical Trials
    • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
    • University of Texas Health Science Center at Houston
    • Department of Experimental Therapeutics

    External person

    Nakia D. Spencer

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Christoph Lauer

    • University of Konstanz

    External person

    Peter J. Shwonek

    • Calithera Biosciences
    • Proteolix, Inc.

    External person

    Jason P. Burke

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Michael Basler

    • University of Konstanz

    External person

    Sonal Gera

    • University of Texas MD Anderson Cancer Center
    • Center for Co-Clinical Trials
    • Institute for Applied Cancer Science

    External person

    Connor A. Parker

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Barbara Czako

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Jing Jiang

    • Proteolix, Inc.

    External person

    Pijus K. Mandal

    • M.D. Anderson Cancer Center
    • Department of Experimental Therapeutics
    • Dept. of Biology and Biochemistry
    • University of Texas MD Anderson Cancer Center
    • University of Houston
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • Department of Experimental Therapeutics
    • University of Texas Health Science Center at Houston

    External person

    Khalid W. Kalim

    • University of Konstanz

    External person

    Simon S. Yu

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Tony Muchamuel

    • Proteolix, Inc.

    External person

    Qi Wu

    • University of Texas MD Anderson Cancer Center

    External person

    Meredith Miller

    • University of Texas MD Anderson Cancer Center

    External person

    Frank O. Nestle

    • King's College London
    • Porter Memorial Hospital - Denver
    • University of Würzburg
    • St John's Institute of Dermatology
    • Guy's Hospital

    External person

    Hyun Seock Shin

    • University of California at Davis

    External person

    M. Eric Gershwin

    • University of California-Davis
    • University of California at Davis
    • Department of Internal Medicine
    • Department of Internal Medicine
    • University of Calgary

    External person

    Edgar Deu

    • Stanford University

    External person

    Yuting Sun

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Center for Co-Clinical Trials
    • University of Texas at Austin
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Anastasia M. Lopez

    • University of Texas MD Anderson Cancer Center

    External person

    Kevin D. Shenk

    • Proteolix, Inc.

    External person

    Elizabeth D. Mellins

    • Stanford University
    • Hematology and Oncology

    External person

    Hideo Tomihara

    • University of Texas MD Anderson Cancer Center
    • Kindai University

    External person

    Yan Lu

    • Proteolix, Inc.

    External person

    Angela K. Deem

    • University of Texas MD Anderson Cancer Center
    • Department of Molecular and Cellular Oncology
    • Center for Co-Clinical Trials
    • Institute for Applied Cancer Science
    • Dept. of Biochem. and Molec. Biology
    • Cornell University
    • Department of Medicine

    External person

    Sarah Johnson

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Jack Davis

    • Shriners Hospitals for Children

    External person

    Maria E. Di Francesco

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • University of Texas at Austin
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Thanh Nguyen

    • Shriners Hospitals for Children

    External person

    Konstantin Levitsky

    • Proteolix, Inc.
    • Onyx Pharmaceuticals

    External person

    Stella R. Hartono

    • University of California at Davis

    External person

    Vijay K. Kuchroo

    • Harvard University
    • Center for Neurologic Diseases, Brigham and Women's Hospital
    • Brigham and Women’s Hospital

    External person

    Vandhana Ramamoorthy

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Department of Sarcoma Medical Oncology
    • Center for Co-Clinical Trials

    External person

    Rene de Waal Malefyt

    • Department of Immunology
    • Merck
    • Immunology Department

    External person

    Frederic Chedin

    • University of California at Davis
    • Department of Molecular and Cellular Biology

    External person

    Ritu Sarin

    • University of California at Davis

    External person

    P. L. Bergsagel

    • M.D. Anderson Cancer Center
    • Mayo Clinic Scottsdale, AZ
    • University of Texas MD Anderson Cancer Center
    • Department of Carcinogenesis
    • Division of Hematology and Oncology
    • Department of Hematology/Oncology
    • Department of Hematology
    • Comprehensive Cancer Center
    • Comprehensive Cancer Center
    • Division of Hematology and Medical Oncology
    • Mayo Clinic Rochester, MN

    External person

    Bhavatarini Vangamudi

    • University of Texas MD Anderson Cancer Center
    • Vanderbilt University
    • Institute for Applied Cancer Science
    • Department of Biochemistry
    • University of Texas Health Science Center at Houston
    • Exo Therapeutics

    External person

    Brooke A. Meyers

    • University of Texas MD Anderson Cancer Center
    • UT MD Anderson Cancer Center
    • Department of Molecular and Cellular Oncology
    • Center for Co-Clinical Trials
    • Institute for Applied Cancer Science

    External person

    Ernesto Guccione

    • Agency for Science, Technology and Research, Singapore
    • Icahn School of Medicine at Mount Sinai

    External person

    Terri McClanahan

    • DNAX Research Institute of Molecular and Cellular Biology
    • Merck
    • Schering-Plough Biopharma
    • Departments of Immunology and Molecular Biology

    External person

    Catherine Stanecki

    • Shriners Hospitals for Children

    External person

    Richard Geissler

    • Stanford University

    External person

    David R. Micklem

    • BerGenBio ASA
    • University of Bergen

    External person

    Mary K. Geck Do

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Institute for Applied Cancer Science
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston

    External person

    Keith Mikule

    • Tesaro Biopharmaceuticals
    • TESARO Inc

    External person

    Paulina Ruurs

    • University of Bergen

    External person

    Christopher P. Vellano

    • University of Texas at Austin
    • University of Texas MD Anderson Cancer Center
    • Center for Co-Clinical Trials
    • University of Texas Health Science Center at Houston
    • Department of Experimental Therapeutics
    • Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION)

    External person

    Sahil Seth

    • Harvard University
    • University of Texas MD Anderson Cancer Center
    • The University of Texas MD Anderson Cancer Center
    • National Institutes of Health
    • University of Texas MD Anderson Cancer Center
    • Department of Genetics
    • Cancer Genome Atlas Program Office
    • Institute for Applied Cancer Science
    • Departments of Bioinformatics
    • Center for Co-Clinical Trials
    • University of Texas Health Science Center at Houston
    • Cornell University
    • Department of Medicine

    External person

    Caroline C. Carrillo

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science

    External person

    Andy M. Zuniga

    • University of Texas MD Anderson Cancer Center

    External person

    Nancy Kohl

    • Merck
    • Dana-Farber Cancer Institute
    • Columbia University
    • Department of Biochemistry and Molecular Biophysics
    • Department of Pediatric Oncology
    • Department of Oncology/Pharmacology
    • Department of Cancer Pathways, Cancer Biology and Therapeutics
    • Department of Oncology
    • Navire Pharma
    • Navire Inc.

    External person

    Susan Lee

    • Onyx Pharmaceuticals
    • Johns Hopkins University
    • Proteolix, Inc.

    External person

    Dennis J. Wu

    • University of California at Davis

    External person

    M. Emilia Di Francesco

    • University of Texas MD Anderson Cancer Center

    External person

    James B. Lorens

    • University of Bergen
    • Department of Biomedicine

    External person

    Benjamin J. Bivona

    • University of Texas MD Anderson Cancer Center

    External person

    Neha Dixit

    • University of California at Davis

    External person

    Christopher C. Williams

    • University of Texas MD Anderson Cancer Center

    External person

    Jason Gay

    • University of Texas MD Anderson Cancer Center
    • Institute for Applied Cancer Science
    • Center for Co-Clinical Trials
    • University of Texas Health Science Center at Houston

    External person

    Zhijun Kang

    • University of Texas MD Anderson Cancer Center

    External person

    Laura Bouchareychas

    • University of California at Davis
    • Northern California Institute for Research and Education
    • University of California at San Francisco

    External person

    Xiao Yan Ma

    • University of Texas MD Anderson Cancer Center
    • University of Texas Health Science Center at Houston

    External person

    Lionel A. Sanz

    • University of California at Davis

    External person

    Jason B. Fleming

    • University of Texas MD Anderson Cancer Center
    • University of South Florida
    • Department of Surgical Oncology

    External person

    Tiffany J. Dickerson

    • University of California at Davis

    External person

    Justin K. Huang

    • University of California at San Diego
    • Department of Medicine
    • La Jolla and San Francisco
    • University of Texas MD Anderson Cancer Center
    • Johns Hopkins University

    External person

    Hong Qui

    • University of California at Davis

    External person

    Ryan E. Knightly

    • University of Texas MD Anderson Cancer Center

    External person

    Jonathan Keats

    • Translational Genomics Research Institute
    • Integrated Cancer Genomics Division

    External person

    Shirin Arastu-Kapur

    • Onyx Pharmaceuticals

    External person

    Jianhua Zhang

    • University of Texas MD Anderson Cancer Center
    • National Institutes of Health
    • Dana-Farber Cancer Institute
    • University of Texas Health Science Center at Houston
    • Belfer Institute for Applied Cancer Science
    • Harvard University
    • Department of Genomic Medicine
    • Belfer Institute for Innovative Cancer Science
    • Broad Institute

    External person

    Alessandro Carugo

    • IRCCS Istituto Europeo di Oncologia - Milano
    • University of Texas MD Anderson Cancer Center
    • Department of Experimental Oncology
    • Department of Molecular and Cellular Oncology
    • Center for Co-Clinical Trials
    • Institute for Applied Cancer Science
    • University of Texas Health Science Center at Houston
    • IRBM S.p.A.

    External person

    Konstantinos S. Zarbalis

    • University of California at Davis
    • Shriners Hospitals for Children

    External person